FAME Trial shows that specific supports can help elderly patients significantly improve compliance with complicated medication regimens
The FAME Trial shows that specific supports for elderly
people such as pre-packaging medications and involving pharmacists in patient
education can significantly improve compliance with complicated medication schedules,
according to a presentation at a Late-Breaking Clinical Trials session at the
American Heart Association meeting. The study is being simultaneously published
in the Journal of the American Medical Association.
The US Federal study of Adherence to Medications in the
Elderly (FAME) is the first trial to examine how to improve elderly patients’
adherence to prescribed medication regimes.
“This comprehensive pharmacy program led to substantial improvements in medical
adherence among elderly patients receiving complex medical regimes, and medication
adherence can result in meaningful improvements in health outcomes,” said Allen
J. Taylor, MD, senior author of the clinical trial and chief of cardiology at
Walter Reed Army Medical Center in Washington, D.C.
In phase one, researchers recruited 200 patients (average age, 78 years) who
were taking four or more daily medications for multiple chronic conditions. Those
enrolled took an average of nine different daily medications. They received educational
material and oral instructions from pharmacists and individualized blister packs
of their medications. Patients met every two months with a pharmacist in this
phase of the study. Adherence rates increased from 61 percent to 97 percent after
six months.
“That’s a previously unseen increase in the degree of medical adherence,”
Taylor said.
Increased adherence also resulted in significant improvements in systolic
blood pressure and low-density lipoprotein cholesterol. For example, systolic
blood pressure dropped on average 3.3 millimeters of mercury (mm Hg), from 133.2
mm Hg to 129.9 mm Hg. Low-density cholesterol levels decreased 4.9 milligrams
per deciliter of blood (mg/dL), from 91.7 mg/dL to 86.8 mg/dL.
In phase two, researchers randomized the same patients to either continue
receiving the education and blister-packed pills or to return to usual care ?
getting their pills in bottles and sorting them themselves.
Those continuing with prepared packaging plus education continued to take
96 percent of their prescribed pills and their blood pressure continued to decrease,
falling by another 5 mm Hg on average at the one-year mark (to 124.4 mm Hg). In
comparison, the usual care group’s adherence fell to 69 percent and their blood
pressure increased to baseline level.
Researchers hand-packaged each patient’s blister pack for morning, noon, evening
and bedtime delivery, aiming to keep their regimen as simple as possible, said
Jeannie Lee, PharmD, a clinical pharmacist at Walter Reed and lead author of the
report.
For example, a patient taking medicine three times a day would receive a morning
pack containing a one-month supply of medications counted out, grouped, labeled
and packaged into each daily morning dose of all appropriate pills, as well as
similar packs for noon and evening. That way they could get all their pills at
once and could tell at a glance if they had taken their medications ? particularly
helpful to patients with memory problems.
“Medication non-adherence among older adults is a widespread and costly problem,”
Taylor said. “Studies indicate that about 65 percent of people who are past retirement
age have two or more chronic conditions, and their typical adherence rates are
60 percent or less.”
Because studies also show that up to 50 percent of cardiovascular admissions
may be due to non-adherence, any measure that improves patient compliance is likely
to have significant personal benefits and coast effectiveness at the national
level.
|